Keita Kobayashi
Overview
Explore the profile of Keita Kobayashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
314
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taoka R, Fukuhara H, Miyake M, Kobayashi K, Ikeda A, Kanao K, et al.
Photodiagnosis Photodyn Ther
. 2025 Mar;
:104554.
PMID: 40086561
Background: This analysis utilized a subject-based analysis of data from the prospective single-arm phase III trial (jRCT2061210055) to evaluate the efficacy of photodynamic diagnosis (PDD) when 5-aminolevulinic acid hydrochloride (5-ALA)...
2.
Tohi Y, Kobayashi K, Daizumoto K, Sekino Y, Fukuhara H, Niigawa H, et al.
Jpn J Clin Oncol
. 2025 Feb;
PMID: 39893578
Objective: To evaluate the real-world clinical usage and effectiveness of apalutamide in men with nonmetastatic castration-resistant prostate cancer (nmCRPC). Methods: We retrospectively reviewed the data of 186 men who received...
3.
Thomsen B, Nagai Y, Kobayashi K, Hamada I, Shiga M
J Chem Phys
. 2024 Nov;
161(20).
PMID: 39601285
The introduction of machine learned potentials (MLPs) has greatly expanded the space available for studying Nuclear Quantum Effects computationally with ab initio path integral (PI) accuracy, with the MLPs' promise...
4.
Tokunaga T, Hirata H, Hitaka Y, Fujii N, Kobayashi K, Hayano T, et al.
Oncol Rep
. 2024 Nov;
53(1).
PMID: 39575481
Long noncoding RNAs (lncRNAs) serve pivotal roles in cancer biology. The present study investigated the oncogenic roles of lncRNAs in renal cell carcinoma (RCC) and their potential as prognostic biomarkers....
5.
Kobayashi K, Fujii N, Shimizu K, Hitaka Y, Oka S, Nakamura K, et al.
Jpn J Clin Oncol
. 2024 Nov;
55(3):290-296.
PMID: 39563501
Background: Bladder preservation therapy for muscle-invasive bladder cancer is reported to yield outcomes comparable to those of radical cystectomy, although it receives a relatively low recommendation grade in Japanese guidelines....
6.
Taoka R, Fukuhara H, Miyake M, Kobayashi K, Ikeda A, Kanao K, et al.
Int J Clin Oncol
. 2024 Nov;
30(1):121-122.
PMID: 39560814
No abstract available.
7.
Shiota M, Nemoto S, Ikegami R, Tatarano S, Kamoto T, Kobayashi K, et al.
BJC Rep
. 2024 Nov;
2(1):69.
PMID: 39516672
Background: The predictive power of the treatment efficacy and prognosis in primary androgen deprivation therapy (ADT) for advanced prostate cancer is not satisfactory. The objective of this study was to...
8.
Hirata H, Fujii N, Oka S, Nakamura K, Shimizu K, Kobayashi K, et al.
Cancer Diagn Progn
. 2024 Nov;
4(6):748-753.
PMID: 39502622
Background/aim: Some patients with renal cell carcinoma (RCC) develop early or late recurrence after surgery. However, there is no clear consensus on which patients with postoperative RCC should be treated....
9.
Jaiswal S, Cox K, Amirfakhri S, Din Parast Saleh A, Kobayashi K, Lwin T, et al.
J Clin Med
. 2024 Oct;
13(20).
PMID: 39458160
Pancreatic cancer is the third leading cause of death related to cancer. The only possible cure presently is complete surgical resection; however, this is limited by difficulty in clearly defining...
10.
Taoka R, Fukuhara H, Miyake M, Kobayashi K, Ikeda A, Kanao K, et al.
Int J Clin Oncol
. 2024 Oct;
30(1):110-120.
PMID: 39375287
Background: In Japan, the authorized period (2-4 h) between oral administration of 5-aminolevulinic acid hydrochloride (5-ALA) and transurethral resection for non-muscle invasive bladder cancer (NMIBC) may restrict photodynamic diagnosis (PDD)...